Tocagen and ApolloBio Enter License Agreement to Develop and Commercialize Toca 511 & Toca FC in China Region
| Target Company Name |
Tocagen Inc. |
|---|---|
| Target Country |
USA |
| Description | Under the terms of the agreement, ApolloBio will make an upfront payment of $16 million to Tocagen, plus potential payments of $4 million in near-term development milestones |
| Global M&A Advisory | Advisor to the buyer |
